Antisense inhibition of angiotensinogen in hepatoma cell culture is enhanced by cationic liposome delivery

Biochemical and Biophysical Research Communications

Volumn 232, Issue 3, 1997, Pages 794-799

  Wielbo, Donna ^a   Shi, Ningya ^a   Sernia, Conrad ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; ANTISENSE OLIGONUCLEOTIDE; LIPOSOME; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR FUNCTION; HEPATOMA CELL; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031587749     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6329     Document Type: Article

References (27)

1. Peters J. Molecular basis of human hypertension: The role of angiotensin. Balliere's Clinical Endocrin Metab. 9:1995;657-678.
2. Jeunemaitre X., Soubrier F., Kotelevtsev K. V., Lifton R. P., Williams C. S., Charru A., Hunt S. C., Hopkins P. N., Williams R. R., Lalouel J. M., Corvol P. Molecular basis of human hypertension: Role of angiotensinogen. Cell. 71:1992;169-180.
3. Hixon J. E., Powers P. K. Detection and characterization of new mutations in the human angiotensinogen gene (AGT). Hum. Genet. 96:1995;110-112.
4. Brashier A. R., Li J., Copland A. Transcription factors modulating angiotensinogen gene expression in hepatocytes. Kidney International. 46:1994;1564-1566.
5. Yakubov L., Deeva E., Zarytova V., Ivanova E., Ryte A., Yurchenko L., Vlassov V. Mechanisms of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. USA. 86:1989;6454-6458.
6. Wahlstedt D., Pich E. M., Koob G. F., Yee F., Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science. 259:1993;528-531.
7. Wahlstedt D., Golanor E., Yamamoto S., Yee F., Ericson H., Yoo H., Inturissi C. E., Reis D. J. Antisense oligonucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischemic infarctions. Nature. 363:1993;260-263.
8. Wielbo D., Sernia C., Phillips M. I. The distribution and antihypertensive effects of phosphorothioated antisense oligodeoxynucleotides in SHR. Hypertension. 25:1995;314-319.
9. Helene C. C., Toulme J. J. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochemica et Biophysica acta. 1049:1990;99-125.
10. Crooke S. T. Progress toward oligonucleotide therapeutics: Pharmacodynamic properties. FASEB J. 7:1993;533-539.
11. Wagner R. W. Gene inhibition using antisense oligodeoxynucleotides. Nature. 372:1994;333-335.
12. Boiziau C., Larrouy B., Moreau S., Cazenave C., Shire D., Toulme J-J. Ribonuclease H-mediated inhibition of translation and reverse transcription by antisense oligodeoxynucleotides. Biochemical Society Transactions. 20:1992;764-767.
13. Sakai R. R., He P. F., Yang Guo, Reilly J. J., Moga C. N., Fluharty S. J. Intracerebroventricular administration of AT1 receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II. J. Neurochem. 62:1994;2053-2056.
14. Meng H., Wielbo D., Gyurko R., Phillips M. I. Antisense inhibition of angiotensin type 1 receptor expression on drinking and vasopressin responses to central angiotensin in sprague-dawley and spontaneously hypertensive rats. Regulatory Peptides. 54:1994;543-551.
15. Morishita R., Gibbons G. H., Ellison K. E., Nakajima M., Zhang L., Kaneda Y., Ogihara T., Dzau V. J. Single ntraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. USA. 90:1993;8474-8478.
16. 1. Regulatory peptides. 49:1993;167-174.
17. Tomita N., Morishita R., Higaki J., Kaneda Y., Mikami H., Ogihara T. In vivo transfer of antisense oligonucleotide against rat angiotensinogen with HJV-liposome delivery resulted in reduction of blood pressure in SHR. Hypertension. 24:1994.
18. Tomita N., Morishita R., Higaki J., Aoki M., Nakamura Y., Mikami H., Fukamizu A., Murakami K., Kaneda Y., Ogihara T. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen. Hypertension. 26:1995;131-136.
19. Wielbo D., Simon A., Phillips M. I., Toffolo S. M. Inhibition of hypertension by peripheral administration of antisense oligodeoxynucleotides. Hypertension. 28:1996;147-151.
20. Ahktar S., Juliano R. L. Cellular uptake and intracellular fate of antisense oligonucleotides. Trends in Cell Biology. 2:1992;139-144.
21. Ohkubo H., Kageyama R., Ujihara M., Hirose T., Inayama S., Nakanishi S. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc. Natl. Acad. Sci. USA. 80:1983;2196-2200.
22. Sernia C., Shinkel T. A., Thomas W. G., Ho K. K. Y., Lincoln D. Angiotensinogen secretion by single rat pituitary cells: Detection by a reverse hemolytic plaque assay and cell identification by immunocytochemistry. Neuroendocrinology. 55:1992;308-316.
23. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
24. S. L. Loke, C. A. Stein, X. H. Zhang, K. Mori, M. Nakanishi, C. Subasinghe, J. S. Cohen, L. M. Neckers, Characterization of oligonucleotide transport into living cells, Proc. Natl. Acad. Sci. USA, 86, 3474, 3478.
25. Temsamani J., Kubert M., Tang J., Padmapriya A., Agrawal S. Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. Antisense Research and Development. 4:1994;35-42.
26. Wickstrom E. Strategies for administering targeted therapeutic oligodeoxynucleotides. Trends-Biotechnol. 10:1992;281-287.
27. Lappalainen K., Urtti A., Soderling E., Jaaskelainen I., Syrjanen K., Syrjanen S. Cationic liposomes improve stability and intracellular delivery of antisense oligonucleotides into CaSki cells. Biochimica et Biophysica Acta. 1196:1994;201-208.